Search the RE article base
Contact Information
Twitter
My TweetsUseful Web Sites
Tag Archives: remdesivir
The Wall Street Journal publishes an editorial against using Bayh-Dole march-in for remdesivir
Sally Pipes has published an op/ed piece at the Wall Street Journal on Bayh-Dole and Gilead, “The Remdesivir Patent Isn’t State Property.” There is so much going on with Pipes’s work. We should take a closer look. First, the title … Continue reading
Posted in Bayh-Dole, high priced medicines, Policy
Tagged Bayh-Dole, ludicrous, march-in, remdesivir
Comments Off on The Wall Street Journal publishes an editorial against using Bayh-Dole march-in for remdesivir
AUTM weighs in on march-in for remdesivir
AUTM has issued a statement on march-in with respect to remdesivir. To date, AUTM has never supported march-in. This new statement is no exception. Howard Bremer, an AUTM founder back when AUTM was SUPA, worked on the implementing regulations for … Continue reading
Posted in Bayh-Dole, high priced medicines, Policy
Tagged AUTM, Bayh-Dole, remdesivir
Comments Off on AUTM weighs in on march-in for remdesivir